Neuroendocrine tumours: choosing the best treatment
An increasing number of new anti-cancer drugs are made available each year. During the authorisation…
Browsing: neuroendocrine tumours
New mutations related to hereditary neuroendocrine tumours
Pheochromocytomas and paragangliomas are rare neuroendocrine tumours with a strong hereditary component. Half the genes…
Updated phase II results of sulfatinib for neuroendocrine tumours
Data from the ongoing phase Ib/II clinical trial of sulfatinib in patients with advanced neuroendocrine…
New drug in development shows improved progression-free survival for patients with advanced metastatic midgut neuroendocrine tumours
A new therapy in development for the treatment of midgut neuroendocrine tumours, a rare type…
Long-term experience supports efficacy and safety of PRRT for treating neuroendocrine tumours
More than ten years of published clinical data and personal experience using peptide receptor radionuclide…
Molecular imaging of neuroendocrine tumours optimises radiotherapy dose
Aggressive neuroendocrine cancer is something of a dark horse—a rare, elusive and persevering force linked…
Targeted hormone-radiation treatment slows growth of midgut neuroendocrine tumours
Early results from a phase III study of patients with previously treated, advanced midgut neuroendocrine…
Everolimus slows growth of neuroendocrine tumours
Researchers report the results of a new analysis from a phase III trial of patients…
License to produce Lutetium-177 for clinical trials
ANSTO announces that a license has been issued by the Therapeutic Goods Administration to produce…